BI
PHAT icon

BVF Inc’s Phathom Pharmaceuticals PHAT Stock Holding History

BVF Inc’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-150,787
Closed -$5.01M – 71
2020
Q4 		$5.01M Sell
150,787
-171,311
-53% -$6.94M 0.2% 58
2020
Q3 		$11.8M Hold
322,098
– – 0.64% 41
2020
Q2 		$10.6M Sell
322,098
-354,463
-52% -$13.6M 0.65% 37
2020
Q1 		$17.5M Sell
676,561
-109,290
-14% -$3.65M 1.63% 19
2019
Q4 		$24.5M Buy
+785,851
New +$19.8M 1.86% 17

Other funds holding PHAT

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc's PHAT Position: Q1 2021 in Review

BVF Inc sold out of Phathom Pharmaceuticals (PHAT) in Q1 2021, closing a stake of 150,787 shares — an estimated $5.01M sold.

BVF Inc first reported a position in PHAT in Q4 2019 and held it in 5 quarters. The position peaked at $24.5M in Q4 2019. 84 funds tracked by Wall St. Rank hold PHAT as of Q1 2021.

  • BVF Inc reported no remaining Phathom Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • BVF Inc sold 150,787 Phathom Pharmaceuticals shares in Q1 2021, an estimated $5.01M.
  • BVF Inc first reported a position in Phathom Pharmaceuticals in Q4 2019 and held it in 5 quarters.
  • BVF Inc's Phathom Pharmaceuticals position peaked at $24.5M in Q4 2019.
  • 84 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2021.

Based on BVF Inc's 13F filing for Q1 2021, filed 17 May 2021.